Researchers

no image

KOMURO Akiyoshi
Lecturer
Faculty Department of Medicine
Researchmap https://researchmap.jp/akiyoshikomuro

Education and Career

Academic & Professional Experience

  • Apr. 2020 - Today , Kindai University Department of Biochemistry, Faculty of Medicine 講師
  • Apr. 2015 - Mar. 2020 , Kindai University Department of Biochemistry, Faculty of Medicine 助教
  • 2010 - 2015 , The University of Tokyo 医学(系)研究科(研究院) 研究員

Research Activities

Research Areas

  • Life sciences, Tumor biology

Research Interests

がん幹細胞, エピジェネティクス, 腫瘍生物学

Published Papers

  1. Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
    Suman Dash; Takeshi Ueda; Akiyoshi Komuro; Masahiko Honda; Ryoichi Sugisawa; Hitoshi Okada
    Cell death & disease  15  (2)  , 131-131, 12, Feb. 2024 
  2. 骨髄系腫瘍におけるNEDD化酵素の腫瘍抑制的な役割
    上田 健; Dash Suman; 本多 賢彦; 古室 暁義; 岡田 斉
    日本生化学会大会プログラム・講演要旨集  96回  , [1P-479], Oct. 2023 
  3. 網羅的CRISPRライブラリースクリーニングによるIFNγ-PD-L1経路制御因子の同定
    岡田 斉; Dash Suman; 本多 賢彦; 古室 暁義; 上田 健
    日本生化学会大会プログラム・講演要旨集  96回  , [1P-493], Oct. 2023 

MORE

MISC

  1. Gemcitabine-resistant PDAC cells with DCK deficiency show upregulated expression of MYC and glutamine target genes. , DASH Suman; 上田健; 古室暁義; 岡田斉 , 日本癌学会学術総会抄録集(Web) , 82nd , 2023
  2. UTX-deficient promotes breast cancer invasion and lung metastasis , 古室暁義; 上田健; DASH Suman; 岡田斉 , 日本癌学会学術総会抄録集(Web) , 82nd , 2023
  3. Functional analysis of Vgll2 in the regulation of skeletal muscle oxidative capacity , 本多賢彦; DASH Suman; 古室暁義; 上田健; 岡田斉 , 日本分子生物学会年会プログラム・要旨集(Web) , 46th , 2023

MORE

Research Grants & Projects

  1. 日本学術振興会, 科学研究費助成事業, エピゲノム制御を介した転移性乳がん発生機構の解明と新規乳がん治療法の開発 , 近畿大学
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Metabolic regulation and the remodeling tissue microenvironment , Kindai University
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Role of histone demethylase in breast cancer progression and finding new therapeutic approaches for breast cancer , Kindai University

MORE